PT1224177E - Processos de preparacao de oxazolinas a partir de tetrahidrofuranos - Google Patents
Processos de preparacao de oxazolinas a partir de tetrahidrofuranosInfo
- Publication number
- PT1224177E PT1224177E PT00970988T PT00970988T PT1224177E PT 1224177 E PT1224177 E PT 1224177E PT 00970988 T PT00970988 T PT 00970988T PT 00970988 T PT00970988 T PT 00970988T PT 1224177 E PT1224177 E PT 1224177E
- Authority
- PT
- Portugal
- Prior art keywords
- preparation
- tetrahydrofuranes
- oxazolin
- preparation processes
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16069599P | 1999-10-21 | 1999-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1224177E true PT1224177E (pt) | 2004-06-30 |
Family
ID=22578030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00970988T PT1224177E (pt) | 1999-10-21 | 2000-10-19 | Processos de preparacao de oxazolinas a partir de tetrahidrofuranos |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6403799B1 (pt) |
| EP (1) | EP1224177B1 (pt) |
| JP (2) | JP2003512361A (pt) |
| KR (1) | KR100706938B1 (pt) |
| CN (3) | CN1539834A (pt) |
| AT (1) | ATE259360T1 (pt) |
| AU (1) | AU775783B2 (pt) |
| BR (1) | BR0015229A (pt) |
| CA (1) | CA2387997C (pt) |
| CZ (1) | CZ20021361A3 (pt) |
| DE (1) | DE60008270T2 (pt) |
| DK (1) | DK1224177T3 (pt) |
| ES (1) | ES2215737T3 (pt) |
| HK (2) | HK1051365A1 (pt) |
| HU (1) | HUP0203214A3 (pt) |
| IL (1) | IL149197A0 (pt) |
| PL (1) | PL364878A1 (pt) |
| PT (1) | PT1224177E (pt) |
| RU (1) | RU2242468C2 (pt) |
| SI (1) | SI1224177T1 (pt) |
| WO (1) | WO2001029013A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2872491T3 (da) | 2012-07-11 | 2021-08-09 | Blueprint Medicines Corp | Inhibitorer af fibroblastvækstfaktorreceptoren |
| CN110028491B (zh) | 2013-10-25 | 2022-02-11 | 缆图药品公司 | 纤维母细胞生长因子受体抑制剂 |
| WO2015108992A1 (en) | 2014-01-15 | 2015-07-23 | Blueprint Medicines Corporation | Heterobicyclic compounds and their use as fgfr4 receptor inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| US5863950A (en) | 1993-01-15 | 1999-01-26 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| SG43809A1 (en) | 1993-02-26 | 1997-11-14 | Schering Corp | 2-benzyl-polycyclic guanine derivatives and process for preparing them |
| US5527829A (en) | 1994-05-23 | 1996-06-18 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
| AU717637B2 (en) * | 1995-09-26 | 2000-03-30 | Agouron Pharmaceuticals, Inc. | Production of amide derivatives and intermediates therefor |
| DE69637770D1 (de) | 1995-09-26 | 2009-01-15 | Agouron Pharma | Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen |
| US5962725A (en) * | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
| US5925759A (en) * | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
| US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
-
2000
- 2000-10-17 US US09/690,093 patent/US6403799B1/en not_active Expired - Fee Related
- 2000-10-19 AT AT00970988T patent/ATE259360T1/de not_active IP Right Cessation
- 2000-10-19 DK DK00970988T patent/DK1224177T3/da active
- 2000-10-19 JP JP2001531813A patent/JP2003512361A/ja active Pending
- 2000-10-19 CN CNA2004100325512A patent/CN1539834A/zh active Pending
- 2000-10-19 SI SI200030333T patent/SI1224177T1/xx unknown
- 2000-10-19 CA CA002387997A patent/CA2387997C/en not_active Expired - Fee Related
- 2000-10-19 WO PCT/US2000/028815 patent/WO2001029013A1/en active IP Right Grant
- 2000-10-19 EP EP00970988A patent/EP1224177B1/en not_active Expired - Lifetime
- 2000-10-19 CN CNB2004100325527A patent/CN1266140C/zh not_active Expired - Fee Related
- 2000-10-19 HU HU0203214A patent/HUP0203214A3/hu unknown
- 2000-10-19 DE DE60008270T patent/DE60008270T2/de not_active Expired - Fee Related
- 2000-10-19 KR KR1020027005084A patent/KR100706938B1/ko not_active IP Right Cessation
- 2000-10-19 PT PT00970988T patent/PT1224177E/pt unknown
- 2000-10-19 AU AU80290/00A patent/AU775783B2/en not_active Ceased
- 2000-10-19 BR BR0015229-3A patent/BR0015229A/pt not_active IP Right Cessation
- 2000-10-19 PL PL00364878A patent/PL364878A1/xx not_active Application Discontinuation
- 2000-10-19 CZ CZ20021361A patent/CZ20021361A3/cs unknown
- 2000-10-19 ES ES00970988T patent/ES2215737T3/es not_active Expired - Lifetime
- 2000-10-19 IL IL14919700A patent/IL149197A0/xx unknown
- 2000-10-19 CN CNB008157871A patent/CN1162408C/zh not_active Expired - Fee Related
- 2000-10-19 RU RU2002113294/04A patent/RU2242468C2/ru active
-
2001
- 2001-11-07 US US09/986,146 patent/US6472534B2/en not_active Expired - Fee Related
-
2002
- 2002-08-26 US US10/227,402 patent/US20030023092A1/en not_active Abandoned
-
2003
- 2003-05-16 HK HK03103473A patent/HK1051365A1/xx not_active IP Right Cessation
-
2005
- 2005-02-16 HK HK05101255A patent/HK1068880A1/xx not_active IP Right Cessation
-
2007
- 2007-09-21 JP JP2007244609A patent/JP2008007522A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1353917T3 (da) | Ny fremgangsmåde til syntesen af 5-(4-fluorphenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrol-3-carboxylsyre phenylamid | |
| NO20024808D0 (no) | Fremgangsmåte ved syntesen av perindopril og farmasöytisk akseptable salter derav | |
| EA200001102A1 (ru) | Способ синтеза ингибиторов сох-2 (циклооксигеназы-2) | |
| UY27362A1 (es) | Métodos de usar inhibidores de epóxido hidrolasa soluble | |
| DE60041584D1 (de) | Substituierte oxoazaheterozyclische verbindungen | |
| NO20006645D0 (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
| DK0835257T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser | |
| NO982850L (no) | Ny syntese | |
| NO984344L (no) | Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger | |
| HK1068880A1 (en) | Process for preparing oxazolines from tetrahydroforans | |
| AR000813A1 (es) | Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas | |
| NO20023150D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| NO20071253L (no) | Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer. | |
| TR200000720T2 (tr) | Kuinolin türevlerinin sentezi için metod. | |
| NO990832L (no) | Syntese av bis-endolylmaleimider | |
| DK1089976T3 (da) | Fremgangsmåde til fremstilling af 5-bromisoquinolin og dets 8-nitroderivat | |
| YU30202A (sh) | Postupak za dobijanje oksazolina iz tetrahidrofurana | |
| DE69930940D1 (de) | Synthese von verbindungen die zur herstellung von ketorolac dienen | |
| ATE271551T1 (de) | Verfahren zur herstellung von n-(1-(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin-n- carboxyanhydrid | |
| RU2003132433A (ru) | Способ получения 2-[5-(4-фторфенил)-3- пиридилметиламинометил]хромана | |
| DE60034571D1 (de) | Festphasensynthese von n,n-disubstituierten diazacycloalkylcarboxy-derivaten | |
| DK1086114T3 (da) | Morfin-6-glucuronidsyntese | |
| RS20050760A (sr) | Postupak za izradu fenilamida 5-(4- fluorofenil)-1-(2-((2r, 4r)-4-hidroksi- 6-okso-tetrahidro-piran-2-il)etil)-2- izopropil-4-fenil-1h-pirol-3- karboksilne kiseline | |
| HRP20020021B1 (en) | Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates | |
| NO20031137D0 (no) | Fremgangsmåte for fremstilling av kirale forbindelser |